Compare Merck & Company (6MK) vs. Competitors

70 Followers

Comparison Results

6MK

Merck & Company

€131.98

€306.31B

112.64

65.01%

14 Buy

6 Hold

0 Sell

Moderate Buy

Bristol-Myers Squibb

$64.72

$120.13B

13.13

32.01%

8 Buy

12 Hold

1 Sell

Moderate Buy

Johnson & Johnson

$273.14

$609.54B

29.45

35.41%

14 Buy

4 Hold

0 Sell

Strong Buy

Novartis

$159.98

$255.98B

21.36

6.46%

3 Buy

3 Hold

1 Sell

Moderate Buy

Pfizer

$28.57

$156.23B

36.32

4.05%

7 Buy

14 Hold

1 Sell

Moderate Buy

AbbVie

$265.79

$469.63B

75.16

15.86%

19 Buy

4 Hold

0 Sell

Strong Buy

xxxxxxxxxxxxx

6MK vs ABBV

xxxxxxxxxxxxx

Performance Comparison

DE:6MK

Merck & Company

125.74

52.28

71.17%

BMY

Bristol-Myers Squibb

59.59

16.83

39.37%

JNJ

Johnson & Johnson

254.78

70.05

37.92%

NVS

Novartis

140.79

11.77

9.12%

PFE

Pfizer

27.50

2.95

12.03%

ABBV

AbbVie

266.69

40.87

18.10%

Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts

Compare More Stocks >